Journal Home
Search for

Volume 121, Issue 2, Pages 202-210 (1 August 2005)


View previous. 16 of 28 View next.

Contraceptive efficacy, compliance and beyond: Factors related to satisfaction with once-weekly transdermal compared with oral contraception

Wolfgang Urdla, Dan Apterb, Alan Alpersteinc, Peter Kolld, Siegfried Schöniane, Jacques Bringerf, Alan C. Fisherg, Michael PreikhCorresponding Author Informationemail address, ORTHO EVRA/EVRA 003 Study Group1

Received 30 August 2004; received in revised form 23 December 2004; accepted 28 January 2005.

Abstract 

Objective:

To investigate contraceptive efficacy, compliance and user's satisfaction with transdermal versus oral contraception (OC).

Study design: Randomized, open-label, parallel-group trial conducted at 65 centers in Europe and South Africa. One thousand four hundred and eighty-nine women received a contraceptive patch (n=846) or an OC (n=643) for 6 or 13 cycles.

Results:

Overall/method-failure Pearl Indices were 0.88/0.66 with the patch and 0.56/0.28 with the OC (p=n.s.). Compliance was higher at all age groups with the patch compared to the OC. Significantly more users were very satisfied with the contraceptive patch than with the OC. The percentage of patch users being very satisfied increased with age whereas it did not in the OC group. Likewise, improvements of premenstrual symptoms as well as emotional and physical well-being increased with age in the patch-group in contrast to the OC group. Ratings of satisfaction with the study medication correlated weakly with emotional (r=0.33) and physical well-being (r=0.39) as well as premenstrual symptoms (r=0.30; p<0.001).

Conclusion:

Contraceptive efficacy of the patch is comparable to OC, but compliance is consistently better at all age groups. Higher satisfaction with the patch at increasing age may be attributed to improvements in emotional and physical well-being as well as reduction of premenstrual symptoms.

a Department for Obstetrics and Gynecology, Unit of Gynecological Endocrinology and Reproductive Medicine, University of Graz, Austria

b The Sexual Health Clinic, Family Federation of Finland, Helsinki, Finland

c University of Cape Town, Groote Schuur Hospital and Kingsbury Hospital, Cape Town, South Africa

d Sandton Medi Clinic, Bryanston, South Africa

e Praxis für Frauenheilkunde, Rheinstetten, Germany

f Hopital Lapeyronie, Montpellier, France

g Ortho-McNeil Pharmaceuticals, Raritan, USA

h Medical and Scientific Affairs, Janssen-Cilag GmbH, Neuss, Germany

Corresponding Author InformationCorresponding author. Tel.: +49 2137 955 376; fax: +49 2137 955 642.

1 G. Freude, H. Kittl, A. Staudach, W. Urdl: Austria; J. Amy, M. Degueldre, M. Dhont, A. van Assche: Belgium; U. Ǻgren, D. Apter, E. Granfors, T. Järvi, H. Polvi, P. Sipilä, S. Telimaa, E. Varila: Finland; G. Body, J. Bringer, G. Chaix-Durand, B. Hedon, J.-L. Meyer, C. Quereux, F. Sailly, E. Signon, M. Tournaire: France; K. Greven, R. Klopfer, U. Kohoutek, L. Koos, S. Schönian, R. Schöpp, K. Stahmer, H.-G. Weidenhammer: Germany; A. Borsos, L. Kovacs, Z. Papp, I. Rákóczi: Hungary; S. Friese, F. Helmerhorst, M.V. Kroeks, A. Pennings, L. Pijpers, F. Roumen, J. Schram, H.K. van Weering: Netherlands; A. Malarewicz, S. Radowicki, S. Rozewicki, P. Skalba, M. Szamatowicz, A. Warenik: Poland; A. Alperstein, J. Baker, H. Cronjé, V.A. Hulme, T. Katzeff, P. Koll, J. Moodley, H.C. Odendaal, L. Reynders, G. Tsalacopoulos, Z.M. van der Spuy: South Africa; A. Campana, M. Germond: Switzerland.

PII: S0301-2115(05)00054-0

doi:10.1016/j.ejogrb.2005.01.021


View previous. 16 of 28 View next.